Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Alcobra reports preclinical data for MG-01CI in mouse model of fragile X syndrome

Sep. 12, 2013

Lundbeck reveals novel NK-3 receptor antagonists

Sep. 12, 2013

Noscira discloses novel GSK-3 inhibitors

Sep. 12, 2013

Biogen Idec and Isis Pharmaceuticals form collaboration for neurological disorders

Sep. 12, 2013

Neurocrine discloses results from phase IIb trial of NBI-98854 for treatment of tardive dyskinesia

Sep. 10, 2013

Spanish team prepares novel sigma1 receptor ligands

Sep. 10, 2013

Neuren Pharmaceuticals cleared to conduct phase II NNZ-2566 trial

Sep. 10, 2013

Lilly presents new mGlu2 positive allosteric modulator for the treatment of anxiety

Sep. 10, 2013

Civitas Therapeutics begins phase IIb study of inhaled levodopa

Sep. 9, 2013

QRxPharma to discuss MoxDuo NDA with FDA prior to refiling

Sep. 9, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026